EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Management of Incomplete Microcirculatory Reperfusion After Endovascular Thrombectomy: Focus on Inhibition of the Glycoprotein IIb/IIIa Receptor Pathway

Neeharika Krothapalli, Thomas Ortel, Devin McBride, Adam de Havenon, Lauren H Sansing, David Hasan, Brian Mac Grory iD

Stroke: Vascular and Interventional Neurology · 2024-03 · 4 (2)

DOI: 10.1161/svin.123.001048 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stroke: Vascular and Interventional Neurology, 2024-03. Verfasst von Neeharika Krothapalli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology University of Connecticut School of Medicine Farmington CT. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endovascular thrombectomy (EVT) is one of the most effective therapies for acute ischemic stroke attributable to large‐vessel occlusion but, despite successful treatment, there remains a significant number of patients with disability. The phenomenon of incomplete microcirculatory reperfusion or no reflow is thought to underlie a substantial proportion of cases with unfavorable outcome. This phenomenon likely arises from platelet aggregation and endothelial edema impacting the cerebral microvasculature, vessels that are below the resolution of digital subtraction angiography. Although incomplete microcirculatory reperfusion prevents tissue recovery and poses a significant clinical challenge, there are multiple therapeutic options administered early after recanalization that have been shown to be promising. In this review, we discuss incomplete microcirculatory reperfusion after EVT and highlight various treatment approaches with a particular focus on antiplatelet therapy, including inhibition of the glycoprotein IIb/IIIa receptor pathway. We also review the rigor of previous studies exploring the use of intravenous and intraarterial administration of tirofiban in neurologic disease before EVT, during EVT, after EVT, or as rescue therapy to determine its effect on clinical outcomes.

Autor:innen und Institutionen

  • Department of Neurology University of Connecticut School of Medicine Farmington CT.
  • Department of Medicine Duke University School of Medicine Durham NC.
  • Department of Neurosurgery McGovern Medical School University of Texas Health Science Center Houston TX.
  • Department of Neurology Center for Brain and Mind Health Yale University School of Medicine New Haven CT.
  • Department of Neurosurgery Duke University School of Medicine Durham NC.
  • Department of Neurology Duke University School of Medicine Durham NC.

ORCID-Profile: Brian Mac Grory

Zitieren

APA

Krothapalli, N., Ortel, T., McBride, D., de Havenon, A., Sansing, L. H., Hasan, D., & Mac Grory, B. (2024). Management of Incomplete Microcirculatory Reperfusion After Endovascular Thrombectomy: Focus on Inhibition of the Glycoprotein IIb/IIIa Receptor Pathway. Stroke: Vascular and Interventional Neurology, 4(2). https://doi.org/10.1161/svin.123.001048

Vancouver

Krothapalli N, Ortel T, McBride D, de Havenon A, Sansing LH, Hasan D, et al. Management of Incomplete Microcirculatory Reperfusion After Endovascular Thrombectomy: Focus on Inhibition of the Glycoprotein IIb/IIIa Receptor Pathway. Stroke: Vascular and Interventional Neurology. 2024;4(2). doi:10.1161/svin.123.001048

BibTeX
@article{Krothapalli2024,
  author = {Krothapalli, Neeharika and Ortel, Thomas and McBride, Devin and de Havenon, Adam and Sansing, Lauren H and Hasan, David and Mac Grory, Brian},
  title = {Management of Incomplete Microcirculatory Reperfusion After Endovascular Thrombectomy: Focus on Inhibition of the Glycoprotein IIb/IIIa Receptor Pathway},
  journal = {Stroke: Vascular and Interventional Neurology},
  year = {2024},
  volume = {4},
  number = {2},
  doi = {10.1161/svin.123.001048}
}
Kostenlos starten →